NCT05367401 A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants Status WITHDRAWN Phase PHASE1/PHASE2
NCT05366257 Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL) Status COMPLETED Phase N/A
NCT05362903 A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting Status COMPLETED Phase N/A
NCT05360446 Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05358249 Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05350072 Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05349214 Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05349201 CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI) Status COMPLETED Phase N/A
NCT05344482 Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase N/A
NCT05344469 A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis Status RECRUITING Phase N/A
NCT05335876 Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials Status RECRUITING Phase PHASE3
NCT05334576 Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA Status UNKNOWN Phase NA
NCT05334472 A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis Status COMPLETED Phase N/A
NCT05330286 Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter. Status TERMINATED Phase PHASE1
NCT05330273 Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz Status COMPLETED Phase PHASE1
NCT05329623 A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants. Status COMPLETED Phase PHASE1
NCT05328752 Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) Status COMPLETED Phase PHASE1
NCT05320159 Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab) Status COMPLETED Phase N/A
NCT05305664 A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany Status COMPLETED Phase PHASE3
NCT05304949 Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity Status COMPLETED Phase N/A